相似文献
1
How to Approach Immune Checkpoint Inhibitor Enterocolitis.
Gastroenterol Hepatol (N Y). 2025 Aug;21(8):501-503.
2
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.
Aliment Pharmacol Ther. 2020 Nov;52(9):1432-1452. doi: 10.1111/apt.15998. Epub 2020 Sep 13.
3
[Clinical and Ultrasound Manifestations of Immune Checkpoint Inhibitor-Associated Enterocolitis:Report of One Case].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025 Aug 4. doi: 10.3881/j.issn.1000-503X.16799.
4
Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Apr 11;26(5):662-668. doi: 10.1093/ibd/izz212.
5
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
Dig Dis Sci. 2022 Apr;67(4):1128-1155. doi: 10.1007/s10620-021-06948-w. Epub 2021 Mar 26.
6
Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.
Immunotherapy. 2023 Aug;15(12):913-920. doi: 10.2217/imt-2022-0245. Epub 2023 Jun 9.
7
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol. 2023 Apr;21(4):878-890. doi: 10.1016/j.cgh.2022.10.004. Epub 2022 Oct 18.
8
Enterocolitis due to immune checkpoint inhibitors: a systematic review.
Gut. 2018 Nov;67(11):2056-2067. doi: 10.1136/gutjnl-2018-316948. Epub 2018 Aug 21.
9
Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Jun 3;30(6):1032-1035. doi: 10.1093/ibd/izad121.
10
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
Cancer. 2023 Feb 1;129(3):367-375. doi: 10.1002/cncr.34543. Epub 2022 Nov 14.
本文引用的文献
1
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007195.
2
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol. 2023 Apr;21(4):878-890. doi: 10.1016/j.cgh.2022.10.004. Epub 2022 Oct 18.
3
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
Dig Dis Sci. 2022 Apr;67(4):1128-1155. doi: 10.1007/s10620-021-06948-w. Epub 2021 Mar 26.
4
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.
Gastroenterology. 2021 Mar;160(4):1384-1393. doi: 10.1053/j.gastro.2020.08.063. Epub 2020 Oct 17.
5
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.
Aliment Pharmacol Ther. 2020 Nov;52(9):1432-1452. doi: 10.1111/apt.15998. Epub 2020 Sep 13.
6
Gut Microbiome and Immune Checkpoint Inhibitor-Induced Enterocolitis.
Dig Dis Sci. 2020 Mar;65(3):797-799. doi: 10.1007/s10620-020-06103-x.
7
Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020 Apr 11;26(5):662-668. doi: 10.1093/ibd/izz212.
Zotero 插件